Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells

Life Sciences

Volumn 60, Issue 2, 1996, Pages 91-100

  Kung, Mei Ping ^a   Stevenson, D Andrew ^a   Zhuang, Zhi Ping ^a   Vessotskie, Janet M ^a   Chumpradit, Sumalee ^a   Sun, Xiao Ming ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

agonist; antagonist; dopamine D4 receptors; G protein coupling; high affinity binding; radioiodinated ligand

Indexed keywords

3 [[4 (4 IODOPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE I 125; DOPAMINE 4 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; HAMSTER; HUNTINGTON CHOREA; LIGAND BINDING; MOLECULAR BIOLOGY; NONHUMAN; PARKINSON DISEASE;

EID: 0030606132     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00598-X     Document Type: Article

References (39)

1. 1. P. SEEMAN, Synapse 1 133-152 (1987).
2. 2. P.G. STRANGE, Biochem. Soc. Trans. 22 155-159 (1994).
3. 3. D.R. SIBLEY AND F.J. MONSMA, JR., Trends Pharmacol. Sci. Rev. 13 61-69 (1992).
4. 4. O. CIVELLI, J.R. BUNZOW AND D.K. GRANDY, Annu. Rev. Pharmacol. Toxicol. 33 281-307 (1993).
5. 5. J.W. KEBABIAN AND D.B. KANE, Nature 277 93 (1979).
6. 6. P.P. SPANO, S. GOVONI AND M. TRABUCCHI, Adv. Biochem. Psychopharmacol. 19 155-165 (1978).
7. 7. H.B. NIZNIK, Mol. Cell. Endocrinol. 54 1-22 (1987).
8. 8. H.H.M. VAN TOL, J.R. BUNZOW, H.C. GUAN, R.K. SUNAHARA, H.B. NIZNIK AND O. CIVELLI, Nature 350 610-614 (1991).
9. 9. C.L. CHIO, F.S. GILL, R.M. HUFF AND I. ABRAHAM, Soc. Neurosci. Abstr. 19 735 (1993).
10. 10. H.H.M. VAN TOL, C.M. WU, H.-C. GUAN, K. OHARA, J.R. BUNZOW, O. CIVELLI, J. KENNEDY, P. SEEMAN, H.B. NIZNIK AND V. JOVANOVIC, Nature 358 149-152 (1992).
11. 11. C.L. CHIO, R.F. DRONG, D.T. RILEY, G.S. GILL, J.L. SLIGHTOM AND R.M. HUFF, J. Biol. Chem. 269 11813-11819 (1994).
12. 12. A. MILLS, B. ALLET, A. BERNARD, C. CHABERT, E. BRANDT, C. CAVEGN, A. CHOLLET AND E. KAWASHIMA, Fed. Eur. Biochem. Soc. Lett. 320 130-134 (1993).
13. 13. C.F. LAWSON, R.A. MORTIMORE, S.K. SCHLACHTER AND M.W. SMITH, Meth. Find. Exp. Clin. Pharmacol. 16 303-307 (1994).
14. 14. L. TANG, R.D. TODD, A. HELLER AND K.L. O'MALLEY, J. Pharmacol. Exp. Ther. 268 495-502 (1994).
15. 15. P. SEEMAN, H.-C. GUAN AND H.H.M. VAN TOL, Nature 365 441-445 (1993).
16. 16. A.M. MURRAY, T.M. HYDE, M.B. KNABLE, M.M. HERMAN, L.B. BIGELOW, J.M. CARTER, D.R. WEINBERGER AND J.E. KLEINMAN, J. Neurosci. 15 2186-2191 (1995).
17. 17. T. SUMIYOSHI, C.A. STOCKMEIER, J.C. OVERHOLSER, L. FRIEDMAN AND H.Y. MELTZER, Soc. Neurosci. Abstr. 20 912 (1994).
18. 18. J.J. KULAGOWSKI, H.B. BROUGHTON, N.R. CURTIS, I.M. MAWER, M.P. RIDGILL, R. BAKER, F. EMMS, S.B. FREEDMAN, R. MARWOOD, S. PATEL, S. PATEL, C.I. RAGAN AND P.D. LEESON, J. Med. Chem. 39 1941-1942 (1996).
19. 19. D.C. HOFFMAN, H. DONOVAN, C.A. BANKOSKI, S.H. LANG, A. THURKAUF, A. HUTCHISON AND J.V. CASSELLA, Soc. Neurosci. Abstr. 21 469 (1995).
20. 20. S.K. SCHLACHTER, T.J. POEL, C.F. LAWSON, D.M. DINH, M.E. LAJINESS, A.G. ROMERO, J.R. PALMER, D.B. CARTER AND M.W. SMITH, Soc. Neurosci. Abstr. 21 618 (1995).
21. 21. R.J. PRIMUS, J. XU, A. THURKAUF, J.F. TALLMAN AND D.W. GALLAGHER, Soc. Neurosci. Abstr. 21 469 (1995).
22. 22. A. LORENZEN, M. FUSS, H. VOGT AND U. SCHWABE, Mol. Pharmacol. 44 115-123 (1993).
23. 23. J.R. TRAYNOR AND S.R. NAHORSKI, Mol. Pharmacol. 47 848-854 (1995).
24. 24. S. CHUMPRADIT, M.-P. KUNG, J.M. VESSOTSKIE AND H.F. KUNG, J. Lab. Compds. Radiopharm. 36 1051-1062 (1995).
25. 25. R. BAKER, N.R. CURTIS, J.J. KULAGOWSKI, P.D. LEESON, M.P. RIDGELL AND A.L. SMITH, Pyrrolo-pyridine derivatives, United Kingdom (1994).
26. 26. M.-P. KUNG AND H.F. KUNG, J. Lab. Compds. Radiopharm. 22 691-700 (1989).
27. 27. S. CHUMPRADIT, M.-P. KUNG, J.M. VESSOTSKIE, C. FOULON, M. MU AND H.F. KUNG, J. Med. Chem. 37 4245-4250 (1994).
28. 28. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR AND R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
29. 29. P.J. MUNSON AND D. RODBARD, J. Recept. Res. 8 533-546 (1980).
30. 30. S. LAZARENO AND N.J.M. BIRDSALL, Br. J. Pharmacol. 109 1120-1127 (1993).
31. 31. M.A.B. TICE, T. HASHEMI, L.A. TAYLOR, R.A. DUFFY AND R.P. MCQUADE, Pharmacol. Biochem. Behav. 42 567-571 (1994).
32. 32. M.J. DURCAN, G.C. RIGDON, M.H. NORMAN AND P.F. MORGAN, Life Sci. 57 275-283 (1995).
33. 33. R.A. LAHTI, D.L. EVANS, N.C. STRATMAN AND L.M. FIGUR, Eur. J. Pharmacol. 236 483-486 (1993).
34. 34. H. SUNDARAM, N.-T. ADRIAN AND P.G. STRANGE, Biochem. Pharmacol. 45 1003-1009 (1993).
35. 35. D.R. SIBLEY AND I. CREESE, J. Biol. Chem. 258 4957-4965 (1983).
36. 36. M.-P. KUNG, D. FREDERICK, M. MU, Z.-P. ZHUANG AND H.F. KUNG, J. Pharmacol. Exp. Ther. 272 429-437 (1995).
37. 37. L.J. SIM, D.E. SELLEY AND S.R. CHILDERS, Proc. Natl. Acad. Sci. U.S.A. 92 7242-7246 (1995).
38. 38. R.M. RICHARDSON AND M.M. HOSEY, J. Biol. Chem. 267 22249-22255 (1992).
39. 39. C. CHABERT, C. CAVEGN, A. BERNARD AND A. MILLS, J. Neurochem. 63 62-65 (1994).